Health & Medicine Week articles from November 2004

Health & Medicine Week archives from November 2004

Experiment finds neurological underpinnings of economic game theory.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Two neuroscientists - Paul Glimcher of New York University (NYU) and Michael Dorris, a former NYU colleague currently at Queens University, Canada - offer evidence for the neurological basis for the...

High body mass index increases risk of carpal tunnel syndrome.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A high body mass index is a risk factor for the development of carpal tunnel syndrome. "In this study we aimed to identify the role of the body mass index (BMI), wrist index, and hand anthropometric...

Gluten-free diet improves growth in diabetics with celiac disease.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A gluten-free diet improved growth and diabetic control in diabetic children with celiac disease. Researchers in Australia studied "the effect of gluten-free diet on growth and diabetic control of...

Knowledge may be hazardous to web consumers' health.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- People who use their computers to find information about their chronic disease often wind up in worse condition than if they had listened to their doctor, according to a new review of studies on...

Science magazine hosts discussion of debate on embryonic stem cell research.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A vigorous debate yesterday among leading research and policy players presented by Scientific American magazine highlighted the connection between the controversies over stem cell research and human...

HIV-1 superinfections assessed by autologous heteroduplex mobility.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Scientists have assessed HIV-1 superinfections in a cohort of commercial sex workers in Burkina Faso by an autologous heteroduplex mobility procedure. In a recently published article, scientists in...

Current state of HIV and AIDS in Sub-Saharan Africa reviewed.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers review the current state of AIDS and HIV in Sub-Saharan Africa in a recent issue of the Croatian Medical Journal. According to a study from Malawi and the United States, "Sub-Saharan...

HIV-1 immunogen vaccine plus antiretrovirals promotes virologic control.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Therapeutic immunization with an inactivated HIV-1 immunogen plus antiretrovirals promotes virologic control in asymptomatic HIV-infected subjects. According to a study from Spain, "To determine...

Estrogen protects male rats from aneurysm.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- When it comes to abdominal aortic aneurysms - life-threatening bulges or weak areas in the main artery feeding blood to the lower half of the body - it is definitely better to be female. During...

FDA approves medical device to treat AAA.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Cook, Inc., a privately held medical-device manufacturer, announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation solution for abdominal aortic aneurysms...

New technique to repair aneurysms safer.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Repairing a life-threatening bulge in a major stomach artery by threading a patch up from the groin appears to sharply cut the short-term risk of death and complications, compared with traditional...

Concentra receives full URAC accreditation in field case management.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Concentra, Inc., has been awarded field case-management accreditation from URAC, a Washington, DC-based healthcare accrediting organization that establishes quality standards for the healthcare...

Multiresistant Acinetobacter baumannii outbreak occurred in surgical room.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Multi-resistant Acinetobacter baumannii outbreak occurred in a surgical room in Germany. "Outbreaks of Acinetobacter baumannii demonstrating multiple antibiotic resistance, including meropenem...

Phase II study of zileuton for moderate-to-severe acne begins.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Critical Therapeutics, Inc., (CRTX), a biopharmaceutical company focused on the discovery, development, and commercialization of products for respiratory, inflammatory, and critical care diseases,...

Loss of clone with FLT3 gene mutation at relapse does not improve AML prognosis.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The loss of a clone with an FLT3 gene mutation at relapse does not improve the prognosis of acute myeloid leukemia. According to recent research from Germany, "Internal tandem duplications (ITDs)...

Genetic profiling links key genes to alcohol-related expectancies.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Genetic profiling links key genes to alcohol-related expectancies. According to recent research from the United States, "molecular genetic research has identified promising markers of alcohol...

U.S. HHS awards grants to treat co-occurring substance abuse/mental disorders.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- U.S. Health and Human Services (HHS) Secretary Tommy G. Thompson announced the award of 4 grants totaling $19.3 million over 5 years to increase the capacity of state treatment systems to provide...

Membrane Cofactor Protein identified as adenovirus receptor.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Membrane Cofactor Protein is identified as the adenovirus receptor. "A tandem mass spectrometry-based approach is demonstrated for detecting a receptor for Ad37, one of the causative agents for...

Growth hormone treatment stimulates adiponectin gene expression in adipocytes.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes. "Growth hormone (GH) is an important regulator of adiposity and systemic energy metabolism. Here,...

Carbohydrate response element-binding protein gene expression studied.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Scientists have studied the modulation of carbohydrate response element-binding protein gene expression in 3T3-L1 adipocytes and rat adipose tissue. "Carbohydrate response element-binding protein...

Measurement site affects estimate of subcutaneous and visceral adiposity.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Measurement site affects the estimate of abdominal subcutaneous and visceral adipose tissue. According to recent research from Canada, "We evaluated the influence of measurement site on the ranking...

Increased insulin not needed for increases in mouse brain tryptophan.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Increased insulin is not required for beta[subscript]2-adrenoceptor-induced increases in mouse brain tryptophan. "The current study tested the hypothesis that beta[subscript]2-adrenoceptor-mediated...

Combination therapy for liver cancer is linked to interstitial pneumonia.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Combination therapy for liver cancer is linked to interstitial pneumonia. According to recent research published in the Journal of Gastroenterology, "previously we reported combined...

Genes involved in valproic acid teratogenicity identified.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Genes involved in teratogenicity induced by the antiepileptic drug valproic acid (VPA) have been identified. "Embryonic development is a highly coordinated set of processes that depend on...

Slightly increased risk of ischemic stroke found with tamoxifen.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers at Duke University Medical Center have found a slightly elevated risk of ischemic stroke due to a blood clot in the brain in patients treated with tamoxifen, a drug commonly prescribed both...

Study documents adverse events of pneumococcal vaccine in children.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Examination of reports from the first 2 years after licensure of a new vaccine against pneumococcal infections indicates that the majority of adverse effects are minor, but that continued surveillance...

Study suggests caution against using certain drugs to unclog heart arteries.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Dartmouth Medical School cardiology researchers have discovered a new mechanism for what drives the growth of muscle tissue in the lining of injured heart vessels that can eventually lead to blockage....

Candela enters exclusive distribution agreement for China.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Candela Corp. (CLZR), a company focused on the development and commercialization of aesthetic laser systems, and Chindex International, Inc., (CHDX), an independent American provider of western...

New technique targets pesticide-resistant insects.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Australian and U.K. scientists have developed a technique to effectively control the "super pests" that are highly resistant to pesticides used on important food and fiber crops worldwide. The...

Ethanol effects on uncoupling protein-1 mRNA alter thermogenesis set point.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The effects of ethanol on uncoupling protein-1 mRNA in brown adipose tissue alter the thermogenesis set point. According to recent research from Japan, "Expression of uncoupling protein-1 (UCP1) is...

Study: Anti-dust mite covers effective in reducing allergens.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A new study provides evidence that people who have allergic asthma and use dust mite-impermeable bed covers have improved peak flow measurements. These findings are featured in the October 2004...

Allergen immunotherapy reviewed.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers review allergen immunotherapy in a recent issue of American Family Physician. According to recent research from the United States, "Allergen immunotherapy (also called allergy vaccine...

NFAT1 protein assists mast cells with interleukin-13 gene transcription.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- NFAT1 protein assists mast cells with interleukin-13 gene transcription. "Th2 and mast cells are participants in the asthmatic response to allergens, and both cell types produce the cytokines...

Patient knowledge of allergy immunotherapy better than expected.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Patient knowledge of allergy immunotherapy was better than expected. "Immunotherapy is an invaluable therapy for allergic asthma, allergic rhinitis, and hymenoptera hypersensitivity. It is, however,...

Female pattern hair loss affects about 30 million U.S. women.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Each year, women spend countless hours and dollars on their hair. It can play a major role in a woman's self-confidence and self-esteem, making female pattern hair loss a potentially debilitating...

Biotechcompany scientist presented with award from Alzheimer Association.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Prana Biotechnology Limited (NASDAQ:PRAN)(NASDAQ:ASX:)(NASDAQ:PBT) announced that Dr. Ashley Ian Bush, cofounding scientist and senior scientific consultant to Prana Biotechnology, was named a 2004...

Blood pressure drugs may slow deterioration of Alzheimer.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Certain blood pressure drugs may slow the deterioration of Alzheimer disease, according to a new study. Called angiotensin-converting enzyme inhibitors, or ACE inhibitors, the drugs are used to...

Degree of upregulation of some antioxidant defenses differs by sex.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Certain antioxidant defense activities occur at higher levels in females than males, and vice versa, study data show. "Since oxidative stress plays an important role in the pathogenesis of...

Forecast: Considerable research to be devoted to pathomechanism of Alzheimer.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Management of Alzheimer disease remains a challenge, with nearly 8 million sufferers from this condition in the 7 major world markets and anticipated increases in the future. Considerable research...

NSAID prodrugs show promise for CNS delivery.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A series of prodrugs of non-steroidal anti-inflammatory drugs (NSAIDs) show promise for CNS delivery of these agents. NSAIDs "have been proposed to prevent or to cure Alzheimer disease," according...

Neuronal transport may play a role in neuritic degeneration.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Neuronal transport may play a role in neuritic degeneration. According to a study from the United States, "The presence of amyloid plaques in the brain is one of the pathological hallmarks of...

Partnership between government, industry will streamline clinical trials.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The U.S. National Institute on Aging (NIA) is launching a landmark study to find neuroimaging and other methods for monitoring the progression of Alzheimer disease (AD) aimed at significantly reducing...

Pharma company announces progress with Alzheimer strategy.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) has made steady progress pursuing a multipronged strategy against Alzheimer disease (AD) that targets the prevention, diagnosis and treatment of AD,...

Pharma company's long-term study of Celebrex expected to continue.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Pfizer Inc. said that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant safety issues and are expected to continue to...

U.S. government to launch major study of Alzheimer patients.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- About 800 older Americans will be asked to lend their brains to science this spring, part of a major government study to track early Alzheimer disease. Researchers will use brain-scanning MRIs and...

p-tau 231 assay improves early stage Alzheimer disease detection.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- An assay developed by Applied NeuroSolutions (APNS), when combined with magnetic resonance imaging (MRI), was shown to identify neural signposts in patients with mild cognitive impairment (MCI), a...

CytRx adds three drug candidates with acquisition of Biorex assets.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- CytRx Corp. (CYTR) has acquired all the clinical and pharmaceutical assets and related intellectual property of Hungary-based Biorex Research & Development, RT, (Biorex), a privately held biotechnology...

Horizon Healthcare Services enters agreement with Ancillary Care Management.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Ancillary Care Management (ACM) announced an agreement with Horizon Healthcare Services, Inc., of New Jersey to deploy ACM's Authorization Management System (AMS) and Claims Management System (CMS). ...

Phase I trial of Hematide initiated.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Affymax, Inc., announced that it has initiated a placebo controlled, phase I dose-finding clinical trial with its lead product candidate, Hematide, a peptide-based erythropoiesis stimulating agent (ESA)...

Study investigates cardiovascular responses to norepinephrine.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers have investigated regional and temporal changes in cardiovascular responses to norepinephrine and vasopressin during continuous infusion of lipopolysaccharide in conscious rats. Reduced...

JCAHO Sentinel Event Alert issued targeted at preventing anesthesia awareness.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Aspect Medical Systems (ASPM) announced that the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) has issued a new Sentinel Event Alert (issue no. 32) aimed at preventing and...

Porcine model study found propofol to be more arrhythmogenic than thiopental.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- An electrophysiological study in a porcine model including acute alcoholic intoxication has been conducted to investigate the comparative effects of thiopental and propofol on atrial vulnerability. ...

Company introduces low permeability AAA Device.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- W. L. Gore & Associates, Inc., a manufacturer of expanded polytetrafluoroethylene (ePTFE) vascular grafts and endovascular devices including the GORE EXCLUDER Bifurcated Endoprosthesis, announced...

Human endothelial cells from different types of vasculature warrant study.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent study investigated homocystein levels, hemostatic risk factors, and restenosis after carotid thromboendarterectomy. Researchers in Norway conducted a prospective, observational study "to...

Microvascular dysfunction encourages the progression of steatohepatitis in mice.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Microvascular dysfunction encourages the progression of steatohepatitis in mice. According to recent research from the United States, "in alcoholic steatohepatitis, hepatic microvascular changes...

Shear-dependent platelet aggregation unaffected by aspirin.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Shear-dependent platelet aggregation was shown to be unaffected by aspirin. According to a study from the United States, "Mechanisms of shear-induced platelet aggregation are not established. Data...

System may aid therapies to lower incidence of acute coronary artery diseases.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent report described an intravascular probe for detection of vulnerable plaque. Investigators in the United States report, "Coronary angiography defines geometry of lumen of artery. However,...

Vitamin E can increase carotid artery compliance and baroreflex gain.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent report described the effect of vitamin E on carotid artery elasticity and baroreflex gain in young, healthy adults. According to published research from Hungary, "In [our] study we tested...

Augmented beta-endorphin is found in patients with coronary artery disease.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers have investigated myocardial and peripheral concentrations of beta-endorphin before and following myocardial ischemia and reperfusion during coronary angioplasty. According to a study...

Abnormally small female knockout mice are incompetent mothers.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Female mice that are abnormally small due to gene knockout technology are also bad mothers whose poor parenting skills cause their young to die within a day or two of birth, scientists reported. ...

New laboratory provides key research into animal diseases.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A new $58 million lab at Michigan State University will be a key to detecting diseases that start in animals but can be transmitted to people. The Diagnostic Center for Population and Animal Health...

Prescriptions for antibiotics to prevent anthrax now uncommon.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Prescriptions for antibiotics that could be taken in advance to prevent against anthrax were uncommon among concerned patients after September 11, 2001 and the 2001 U.S. anthrax attacks, according to a...

Researchers begin evaluating efficacy of JuvImmune immunostimulant platform.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Juvaris BioTherapeutics, Inc., announced that researchers at the University of New Mexico have begun evaluating the efficacy of the JuvImmune immunostimulant platform against anthrax and small pox...

Study of primary care doctors' response to 2001 attacks shows prudent care.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Primary care physicians working only blocks away from the New York City anthrax attacks of October 2001 acted responsibly and rationally in the midst of the crisis, according to New York-Presbyterian...

Biotech company working to address problem of antibiotic resistance.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- New biotechnology company, RiboNovix, Inc., is addressing the worsening problem of antibiotic-resistant bacteria by developing new anti-infectives that are less susceptible to drug resistance. Over...

Oral fluconazole safe/effective empiric treatment for neutropenic fever.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Oral fluconazole is a safe and effective empiric treatment for persistent neutropenic fever. According to a study from Israel, "Neutropenic patients who continue to be febrile despite adequate...

Elemental sulphur studied as an induced antifungal substance.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Elemental sulphur has been studied as an induced antifungal substance. "Man's oldest fungicide has probably long functioned in this role in plants, as a natural component of induced antifungal...

Abnormal homocysteine metabolism not key factor in autoimmune disorder.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Study results suggest abnormal homocysteine metabolism is not a key factor in the development of antiphospholipid syndrome. "Recent studies have identified hyperhomocysteinemia as a risk factor for...

Antisense inhibitors of TRADD could modulate TNF-related pathologies.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Antisense inhibitors of TRADD could modulate TNF-related pathologies. "Tumor necrosis factor (TNF) receptor 1-associated death domain protein (TRADD) is an adaptor protein known to be involved in...

The antisense mRNA sONE offers endothelial-cell specific gene expression.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The antisense mRNA sONE offers endothelial-cell specific gene expression. According to a study from Canada, "endothelial nitric-oxide synthase (eNOS) mRNA levels are abnormal in diseases of the...

Antiestrogenic drug combinations may be used for glioblastoma malignancies.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Antiestrogenic drug combinations may be used for glioblastoma malignancies. According to researchers in Turkey, "The antitumor activity of nonsteroidal antiestrogens on C6 and low passage of human...

RANTES haplotypes influence the response to chronic hepatitis C therapy.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- RANTES haplotypes influence the response to chronic hepatitis C therapy. "The response to antiviral therapy for chronic hepatitis C virus (HCV) is complex and is determined by both environmental and...

CD45 plays significant role in nuclear apoptosis by chloride channel regulation.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- CD45 plays a significant role in nuclear apoptosis by chloride channel regulation. According to published research from Canada, "Mitochondrial-perturbating agents such as toxic compounds induce...

Humic acid induces apoptosis in premyelocytic leukemia HL-60 cells.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Humic acid induces apoptosis in promyelocytic leukemia HL-60 cells. According to a study from Taiwan, "It has been shown that humic acid (HA), a phenolic polymer, exhibits pro-oxidant and cytotoxic...

FDA approves first U.S. implants of Philos II DR-T pacemaker.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Biotronik, Inc., announced U.S. Food and Drug Administration (FDA) approval and first implants of a second-generation Home Monitoring product: the Philos II DR-T pacemaker. The device is part of a...

Synthetic zeolites used for arsenate removal from pollutant water.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Synthetic zeolites are used for arsenate removal from pollutant water. "Arsenic is known to be a hazardous contaminant in drinking water that causes arsenical dermatitis and skin cancer. In the...

Pharmaceutical company offers its alternative to recalled arthritis medication.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- With the recent recall of the arthritis medication rofecoxib, Boehringer Ingelheim announced that it is supporting patients while they look for new alternatives. The company offered up its own...

Research shows gelatine stimulates synthesis of type II collagen.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Collagen hydrolysate (CH), a special type of gelatine, was shown to stimulate synthesis of type II collagen in a study presented at the annual meeting of the American Society for Bone and Mineral...

Topical medication effective in relieving symptoms of knee osteoarthritis.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Symptoms of primary osteoarthritis of the knee, including pain and stiffness, were significantly improved in patients who used a topical nonsteroidal anti-inflammatory drug (NSAID), according to new...

Glucuronoxylomannan exhibits anti-inflammatory effects in arthritis.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Glucuronoxylomannan exhibits anti-inflammatory effects in collagen-induced arthritis. "This investigation was planned to assess the therapeutic efficacy of glucuronoxylomannan (GXM) in...

Bioassay detects soluble MAdCAM-1 in body fluids.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers have developed a bioassay to detect soluble MAdCAM-1 in body fluids. According to recent research from New Zealand, "Mucosal addressin cell adhesion molecule (MAdCAM-1) is a key player...

Company addresses possible reimbursement for VentrAssist LVAS.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Ventracor, Ltd., (VCR), said there was evidence the cost of its artificial heart devices used in its pending U.S. clinical trials would be fully reimbursed and there was potential for reimbursement at...

Review finds recombinant FSH is more effective therapy for inducing ovulation.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Recombinant follicle stimulating hormone (FSH) is more effective than urinary FSH therapy for inducing ovulation, concludes a recent review article. "Infertility affects approximately 10%-15% of...

Study will look at how professionals approach the complex ethics of IVF.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- How do health professionals approach the complex and sensitive ethics of in vitro fertilization (IVF) and embryo research in their work? While there is a great deal of public debate on contentious...